Clinical trial
Blood Samples to Evaluate Immune Response to Provenge® (Sipuleucel-T) inHormone Refractory Metastatic Prostate Cancer Patients
NCT01274572 is registered in ClinicalTrials.gov with Mary Crowley Medical Research Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Blood Samples to Evaluate Immune Response to Provenge® (Sipuleucel-T) inHormone Refractory Metastatic Prostate Cancer Patients
- Lead sponsor
- Mary Crowley Medical Research Center
- Phase
- Observational
- Overall status
- Withdrawn
- Start date
- January 31, 2011
- Completion date
- June 30, 2011
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
prostate cancer